From SOMAmer-Based Biomarker Discovery to Diagnostic and Clinical Applications: A SOMAmer-Based, Streamlined Multiplex Proteomic Assay
Open accessThe DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Abstract
Recently, we reported a SOMAmer-based, highly multiplexed assay for the purpose of biomarker identification. To enable seamless transition from highly multiplexed biomarker discovery assays to a format suitable and convenient for diagnostic and life-science applications, we developed a streamlined, plate-based version of the assay. The plate-based version of the assay is robust, sensitive (sub-picomolar), rapid, can be highly multiplexed (upwards of 60 analytes), and fully automated. We demonstrate that quantification by microarray-based hybridization, Luminex bead-based methods, and qPCR are each compatible with our platform, further expanding the breadth of proteomic applications for a wide user community.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The technological advance in mass spectrometry (MS) and protein separation now allows rapid and accurate detection of hundreds of human proteins and peptides from a small amount of body fluid or tissue (Kraemer et al., 2011).”
From Integrative Analysis of Multi-omics Data for Discovery and Functional Studies of Complex Human Diseases (2016) · cites this paper as Kraemer et al., 2011
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tuerk, C., & Gold, L. (1990) · Science · doi:10.1126/science.2200121 · Cited by 10,405
Self-citationIn vitro selection of RNA molecules that bind specific ligands
Ellington, A. D., & Szostak, J. W. (1990) · Nature · doi:10.1038/346818a0 · Cited by 9,812
Aptamer-Based Multiplexed Proteomic Technology for Biomarker Discovery
Gold, L., Ayers, D., Bertino, J., Bock, C., Bock, A., Brody, E. N., Carter, J., Dalby, A. B., Eaton, B. E., Fitzwater, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015004 · Cited by 1,754
Self-citationFunctional Aptamers and Aptazymes in Biotechnology, Diagnostics, and Therapy
Famulok, M., Hartig, J. S., & Mayer, G. (2007) · Chemical Reviews · doi:10.1021/cr0306743 · Cited by 887
Aptamers as therapeutic and diagnostic agents
Brody, E. N., & Gold, L. (2000) · Reviews in Molecular Biotechnology · doi:10.1016/s1389-0352(99)00004-5 · Cited by 494
Self-citationExpanding the Chemistry of DNA for in Vitro Selection
Vaught, J. D., Bock, C., Carter, J., Fitzwater, T., Otis, M., Schneider, D., Rolando, J., Waugh, S., Wilcox, S. K., & Eaton, B. E. (2010) · Journal of the American Chemical Society · doi:10.1021/ja908035g · Cited by 313
Self-citationOligonucleotides as Research, Diagnostic, and Therapeutic Agents
Gold, L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13581 · Cited by 266
Self-citationOstroff, R., Bigbee, W., Franklin, W., Gold, L., Mehan, M., Miller, Y., Pass, H., Rom, W., Siegfried, J., Stewart, A., et al. (2010) · Nature Precedings · doi:10.1038/npre.2010.4537.1 · Cited by 213
Self-citationProteomics and diagnostics: Let's Get Specific, again
Zichi, D., Eaton, B. E., Singer, B. S., & Gold, L. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.01.016 · Cited by 82
Self-citationThe pre‐omics era: The early days of two‐dimensional gels
O’Farrell, P. H. (2008) · PROTEOMICS · doi:10.1002/pmic.200800719 · Cited by 35
Cited by
Connecting genetic risk to disease end points through the human blood plasma proteome
Suhre, K., Arnold, M., Bhagwat, A. M., Cotton, R. J., Engelke, R., Raffler, J., Sarwath, H., Thareja, G., Wahl, A., DeLisle, R. K., et al. (2017) · Nature Communications · doi:10.1038/ncomms14357 · Cited by 800
Self-citationAptamer-Based Detection of Circulating Targets for Precision Medicine
Wu, L., Wang, Y., Xu, X., Liu, Y., Lin, B., Zhang, M., Zhang, J., Wan, S., Yang, C., & Tan, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01140 · Cited by 705
Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy
Sun, H., Zhu, X., Lu, P. Y., Rosato, R. R., Tan, W., & Zu, Y. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.32 · Cited by 541
Rohloff, J. C., Gelinas, A. D., Jarvis, T. C., Ochsner, U. A., Schneider, D. J., Gold, L., & Janjic, N. (2014) · Molecular Therapy - Nucleic Acids · doi:10.1038/mtna.2014.49 · Cited by 533
Self-citationAptamer-based targeted therapy
Zhu, G., & Chen, X. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.08.005 · Cited by 522
Sun, Y. V., & Hu, Y.-J. (2016) · Advances in Genetics · doi:10.1016/bs.adgen.2015.11.004 · Cited by 459
“The technological advance in mass spectrometry (MS) and protein separation now allows rapid and accurate detection of hundreds of human proteins and peptides from a small amount of body fluid or tissue (Kraemer et al., 2011).”
BackgroundSeok Kim, Y., Ahmad Raston, N. H., & Bock Gu, M. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2015.06.040 · Cited by 442
Aptamers in the Therapeutics and Diagnostics Pipelines
Kaur, H., Bruno, J. G., Kumar, A., & Sharma, T. K. (2018) · Theranostics · doi:10.7150/thno.25958 · Cited by 366
Ganz, P., Heidecker, B., Hveem, K., Jonasson, C., Kato, S., Segal, M. R., Sterling, D. G., & Williams, S. A. (2016) · JAMA · doi:10.1001/jama.2016.5951 · Cited by 364
Advancement of the emerging field of RNA nanotechnology
Jasinski, D., Haque, F., Binzel, D. W., & Guo, P. (2017) · ACS Nano · doi:10.1021/acsnano.6b05737 · Cited by 352
In vitro selection with artificial expanded genetic information systems
Sefah, K., Yang, Z., Bradley, K. M., Hoshika, S., Jiménez, E., Zhang, L., Zhu, G., Shanker, S., Yu, F., Turek, D., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311778111 · Cited by 330
Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
Ni, S., Yao, H., Wang, L., Lu, J., Jiang, F., Lu, A., & Zhang, G. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081683 · Cited by 321
A Highlight of Recent Advances in Aptamer Technology and Its Application
Sun, H., & Zu, Y. (2015) · Molecules · doi:10.3390/molecules200711959 · Cited by 316
Aptamers and the next generation of diagnostic reagents
Thiviyanathan, V., & Gorenstein, D. G. (2012) · PROTEOMICS – Clinical Applications · doi:10.1002/prca.201200042 · Cited by 275
Nucleic acid aptamers in cancer research, diagnosis and therapy
Ma, H., Liu, J., Ali, M. M., Mahmood, M. A. I., Labanieh, L., Lu, M., Iqbal, S. M., Zhang, Q., Zhao, W., & Wan, Y. (2015) · Chemical Society Reviews · doi:10.1039/c4cs00357h · Cited by 265
Advances in human proteomics at high scale with the SOMAscan proteomics platform
Gold, L., Walker, J. J., Wilcox, S. K., & Williams, S. (2012) · New Biotechnology · doi:10.1016/j.nbt.2011.11.016 · Cited by 261
Self-citationAptamer Nanomedicine for Cancer Therapeutics: Barriers and Potential for Translation
Lao, Y.-H., Phua, K. K. L., & Leong, K. W. (2015) · ACS Nano · doi:10.1021/nn507494p · Cited by 259
Advances in targeted proteomics and applications to biomedical research
Shi, T., Song, E., Nie, S., Rodland, K. D., Liu, T., Qian, W., & Smith, R. D. (2016) · PROTEOMICS · doi:10.1002/pmic.201500449 · Cited by 257
SELEX methods on the road to protein targeting with nucleic acid aptamers
Bayat, P., Nosrati, R., Alibolandi, M., Rafatpanah, H., Abnous, K., Khedri, M., & Ramezani, M. (2018) · Biochimie · doi:10.1016/j.biochi.2018.09.001 · Cited by 241
Malignant pleural mesothelioma: history, controversy and future of a manmade epidemic
Røe, O. D., & Stella, G. M. (2015) · European Respiratory Review · doi:10.1183/09059180.00007014 · Cited by 185
Updates on Acute Coronary Syndrome: A Review
Eisen, A., Giugliano, R. P., & Braunwald, E. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.2049 · Cited by 185
Aptamers and Their Applications in Nanomedicine
Sun, H., & Zu, Y. (2015) · Small · doi:10.1002/smll.201403073 · Cited by 180
Brown, A., Brill, J., Amini, R., Nurmi, C., & Li, Y. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202318665 · Cited by 175
ABCs of DNA aptamer and related assay development
Sharma, T. K., Bruno, J. G., & Dhiman, A. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.01.003 · Cited by 174
Stability and reproducibility of proteomic profiles measured with an aptamer-based platform
Kim, C. H., Tworoger, S. S., Stampfer, M. J., Dillon, S. T., Gu, X., Sawyer, S. J., Chan, A. T., Libermann, T. A., & Eliassen, A. H. (2018) · Scientific Reports · doi:10.1038/s41598-018-26640-w · Cited by 170
Aptamers from random sequence space: Accomplishments, gaps and future considerations
Qian, S., Chang, D., He, S., & Li, Y. (2022) · Analytica Chimica Acta · doi:10.1016/j.aca.2022.339511 · Cited by 161
Molecular Elucidation of Disease Biomarkers at the Interface of Chemistry and Biology
Zhang, L., Wan, S., Jiang, Y. Y., Wang, Y., Fu, T., Liu, Q., Cao, Z., Qiu, L., & Tan, W. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b10646 · Cited by 146
Nucleic Acid Therapeutics: Successes, Milestones, and Upcoming Innovation
Belgrad, J., Fakih, H. H., & Khvorova, A. (2024) · Nucleic Acid Therapeutics · doi:10.1089/nat.2023.0068 · Cited by 142
Ostroff, R. M., Mehan, M. R., Stewart, A., Ayers, D., Brody, E. N., Williams, S. A., Levin, S., Black, B., Harbut, M., Carbone, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046091 · Cited by 138
Aptamers: versatile molecular recognition probes for cancer detection
Sun, H., Tan, W., & Zu, Y. (2016) · The Analyst · doi:10.1039/c5an01995h · Cited by 135
Genetic alphabet expansion technology by creating unnatural base pairs
Kimoto, M., & Hirao, I. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00457j · Cited by 129
Kahal, H., Halama, A., Aburima, A. A., Bhagwat, A. M., Butler, A. E., Graumann, J., Suhre, K., Sathyapalan, T., & Atkin, S. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-61531-z · Cited by 125
Spatial multi-omics: novel tools to study the complexity of cardiovascular diseases
Kießling, P., & Kuppe, C. (2024) · Genome Medicine · doi:10.1186/s13073-024-01282-y · Cited by 121
Aptamers in biomedicine: Selection strategies and recent advances
Ștefan, G., Hosu, O., Wael, K. D., Lobo-Castañón, M. J., & Cristea, C. (2021) · Electrochimica Acta · doi:10.1016/j.electacta.2021.137994 · Cited by 120
Progress and Trends in Complement Therapeutics
Ricklin, D., & Lambris, J. D. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-4118-2_1 · Cited by 119
The established and future biomarkers of malignant pleural mesothelioma
Panou, V., Vyberg, M., Weinreich, U. M., Meristoudis, C., Falkmer, S., & Røe, O. D. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.05.001 · Cited by 116
Wang, Y. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.03.008 · Cited by 114
Current Progress of Aptamer-Based Molecular Imaging
Wang, A. Z., & Farokhzad, O. C. (2014) · Journal of Nuclear Medicine · doi:10.2967/jnumed.113.126144 · Cited by 112
Beyond antibodies: New affinity reagents to unlock the proteome
Lollo, B., Steele, F., & Gold, L. (2014) · PROTEOMICS · doi:10.1002/pmic.201300187 · Cited by 110
Self-citationAge-Dependent Changes in the Cerebrospinal Fluid Proteome by Slow Off-Rate Modified Aptamer Array
Baird, G. S., Nelson, S. K., Keeney, T. R., Stewart, A., Williams, S., Kraemer, S., Peskind, E. R., & Montine, T. J. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.10.024 · Cited by 110
Self-citationTranslation of aptamers toward clinical diagnosis and commercialization
Liu, S., Xu, Y., Xin, J., Tan, H., & Ying, B. (2022) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2022.114168 · Cited by 110
Alternative Watson–Crick Synthetic Genetic Systems
Benner, S. A., Karalkar, N. B., Hoshika, S., Laos, R., Shaw, R. W., Matsuura, M., Fajardo, D., & Moussatche, P. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023770 · Cited by 98
Liquid biomarkers in melanoma: detection and discovery
Lim, S. Y., Lee, J., Diefenbach, R. J., Kefford, R. F., & Rizos, H. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0757-5 · Cited by 104
Revealing the role of the human blood plasma proteome in obesity using genetic drivers
Zaghlool, S. B., Sharma, S., Molnar, M., Matías-García, P. R., Elhadad, M. A., Waldenberger, M., Peters, A., Rathmann, W., Graumann, J., Gieger, C., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21542-4 · Cited by 102
Utilizing population variation, vaccination, and systems biology to study human immunology
Tsang, J. S. (2015) · Trends in Immunology · doi:10.1016/j.it.2015.06.005 · Cited by 102
Semba, R. D., Gonzalez-Freire, M., Tanaka, T., Biancotto, A., Zhang, P., Shardell, M., Moaddel, R., CHI Consortium, & Ferrucci, L. (2020) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz071 · Cited by 94
Development of Phosphorothioate DNA and DNA Thioaptamers
Volk, D. E., & Lokesh, G. L.-R. (2017) · Biomedicines · doi:10.3390/biomedicines5030041 · Cited by 93
Zhang, L., Yang, Z., Trinh, T. L., Teng, I., Wang, S., Bradley, K. M., Hoshika, S., Wu, Q., Cansız, S., Rowold, D. J., et al. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201605058 · Cited by 92
Biosensors based on aptamer‐conjugated gold nanoparticles: A review
Nooranian, S., Mohammadinejad, A., Mohajeri, T., Aleyaghoob, G., & Oskuee, R. K. (2021) · Biotechnology and Applied Biochemistry · doi:10.1002/bab.2224 · Cited by 92
Biondi, E., Lane, J. D., Das, D., DasGupta, S., Piccirilli, J. A., Hoshika, S., Bradley, K. M., Krantz, B. A., & Benner, S. A. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw890 · Cited by 90
Validation of a blood protein signature for non-small cell lung cancer
Mehan, M. R., Williams, S. A., Siegfried, J. M., Bigbee, W. L., Weissfeld, J. L., Wilson, D. O., Pass, H. I., Rom, W. N., Muley, T., Meister, M. A., et al. (2014) · Clinical Proteomics · doi:10.1186/1559-0275-11-32 · Cited by 86
Zaghlool, S. B., Kühnel, B., Elhadad, M. A., Kader, S. A., Halama, A., Thareja, G., Engelke, R., Sarwath, H., Al‐Dous, E., Mohamoud, Y. A., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13831-w · Cited by 83
Selmi, C. F., Ceribelli, A., Generali, E., Scirè, C. A., Alborghetti, F., Colloredo, G., Porrati, L., Achenza, M. I. S., Santis, M. D., Cavaciocchi, F., et al. (2015) · Autoimmunity Reviews · doi:10.1016/j.autrev.2015.10.007 · Cited by 74
Using aptamers for targeted delivery of RNA therapies
Driscoll, J., Gondaliya, P., Zinn, D. A., Jain, R., Yan, I. K., Dong, H., & Patel, T. C. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.02.047 · Cited by 73
Dressed for success – applying chemistry to modulate aptamer functionality
Tölle, F., & Mayer, G. (2012) · Chemical Science · doi:10.1039/c2sc21510a · Cited by 72
Opportunities for Sensitive Plasma Proteome Analysis
Landegren, U. D., Vänelid, J., Hammond, M., Nong, R. Y., Wu, D., Ullerås, E., & Kamali‐Moghaddam, M. (2012) · Analytical Chemistry · doi:10.1021/ac2032222 · Cited by 76
Graumann, J., Finkernagel, F., Reinartz, S., Stief, T., Brödje, D., Renz, H., Jansen, J. M., Wagner, U., Worzfeld, T., Pogge von Strandmann, E., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01150 · Cited by 67
Aptamer-based proteomic signature of intensive phase treatment response in pulmonary tuberculosis
Nahid, P., Bliven-Sizemore, E., Jarlsberg, L. G., Groote, M. A. D., Johnson, J. L., Muzanyi, G., Engle, M., WEINER, M. H., Janjić, N., Sterling, D. G., et al. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.01.006 · Cited by 67
Posavi, M., Diaz-Ortiz, M., Liu, B., Swanson, C. R., Skrinak, R. T., Hernandez-Con, P., Amado, D. A., Fullard, M., Rick, J., Siderowf, A., et al. (2019) · PLOS Medicine · doi:10.1371/journal.pmed.1002931 · Cited by 66
Aptasensors for the detection of infectious pathogens: design strategies and point-of-care testing
Chen, X., Zhao, X., & Yang, Z. (2022) · Microchimica Acta · doi:10.1007/s00604-022-05533-w · Cited by 66
Comprehensive Proteomics Profiling Reveals Circulating Biomarkers of Hypertrophic Cardiomyopathy
Shimada, Y. J., Raita, Y., Liang, L. W., Maurer, M. S., Hasegawa, K., Fifer, M. A., & Reilly, M. P. (2021) · Circulation Heart Failure · doi:10.1161/circheartfailure.120.007849 · Cited by 66
Increasing hybridization rate and sensitivity of DNA microarrays using isotachophoresis
Han, C. M., Katilius, E., & Santiago, J. G. (2014) · Lab on a Chip · doi:10.1039/c4lc00374h · Cited by 62
Self-citationMolecular‐based diagnosis of multiple sclerosis and its progressive stage
Barbour, C. R., Kosa, P. F., Komori, M., Tanigawa, M., Masvekar, R., Wu, T., Johnson, K. R., Douvaras, P., Fossati, V., Herbst, R., et al. (2017) · Annals of Neurology · doi:10.1002/ana.25083 · Cited by 60
Plasma proteomic signature of the risk of developing mobility disability: A 9‐year follow‐up
Osawa, Y., Semba, R. D., Fantoni, G., Candia, J., Biancotto, A., Tanaka, T., Bandinelli, S., & Ferrucci, L. (2020) · Aging Cell · doi:10.1111/acel.13132 · Cited by 59
Deep molecular phenotypes link complex disorders and physiological insult to CpG methylation
Zaghlool, S. B., Mook‐Kanamori, D. O., Kader, S. A., Stephan, N., Halama, A., Engelke, R., Sarwath, H., Al‐Dous, E., Mohamoud, Y. A., Roemisch‐Margl, W., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy006 · Cited by 59
Wood, G. C., Chu, X., Argyropoulos, G., Benotti, P., Rolston, D., Mirshahi, T., Petrick, A., Gabrielson, J., Carey, D. J., DiStefano, J. K., et al. (2017) · Scientific Reports · doi:10.1038/srep43238 · Cited by 56
Kraemer, S., Schneider, D. J., Paterson, C., Perry, D., Westacott, M. J., Hagar, Y., Katilius, E., Lynch, S. A., Russell, T. M., Johnson, T., et al. (2024) · Journal of Proteome Research · doi:10.1021/acs.jproteome.4c00411 · Cited by 57
Self-citationAptamers: Molecular Tools for Medical Diagnosis
Özalp, V. C., Kavruk, M., Dilek, Ö., & Bayraç, A. T. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150413154233 · Cited by 56
Diagnosis and Prognosis-Review of Biomarkers for Mesothelioma
Sun, H. H., Vaynblat, A., & Pass, H. I. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.06.60 · Cited by 55
Finkernagel, F., Reinartz, S., Schuldner, M., Malz, A., Jansen, J. M., Wagner, U., Worzfeld, T., Graumann, J., von Strandmann, E. P., & Müller, R. (2019) · Theranostics · doi:10.7150/thno.37549 · Cited by 55
Life's Simple Measures: Unlocking the Proteome
Brody, E., Gold, L., Mehan, M., Ostroff, R., Rohloff, J., Walker, J., & Zichi, D. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.06.021 · Cited by 54
“The key to using SOMAmers to measure all these proteins simultaneously in under 100 μL of serum or plasma is a resultant of their intrinsic specificity and sensitivity and of our ability to reduce biological background in the samples.(9) Figure 2 shows a cartoon of the structure of each SOMAmer used in the mixture of…”
Self-citationPetek, L. M., Rickard, A. M., Budech, C. B., Poliachik, S. L., Shaw, D., Ferguson, M. R., Tawil, R., Friedman, S. D., & Miller, D. G. (2016) · Neuromuscular Disorders · doi:10.1016/j.nmd.2016.04.012 · Cited by 54
Bayramoğlu, G., Özalp, V. C., Dincbal, U., & Arica, M. Y. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00018 · Cited by 54
Komarova, N. V., Panova, O. S., Titov, A., & Kuznetsov, A. E. (2022) · Biomedicines · doi:10.3390/biomedicines10051085 · Cited by 51
Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology
Voyle, N., Baker, D., Burnham, S. C., Covin, A., Zhang, Z., Sangurdekar, D. P., Tan Hehir, C. A., Bazenet, C., Lovestone, S., Kiddle, S., et al. (2015) · Journal of Alzheimer’s Disease · doi:10.3233/jad-150020 · Cited by 50
Systematic Optimization and Modification of a DNA Aptamer with 2’‐O‐Methyl RNA Analogues
Maio, G. E., Enweronye, O., Zümrüt, H. E., Batool, S., Van, N. A., & Mallikaratchy, P. R. (2017) · ChemistrySelect · doi:10.1002/slct.201700359 · Cited by 49
Development of a Protein Biomarker Panel to Detect Non–Small-Cell Lung Cancer in Korea
Jung, Y. J., Katilius, E., Ostroff, R. M., Kim, Y., Seok, M., Lee, S., Jang, S., Kim, W. S., & Choi, C. (2016) · Clinical Lung Cancer · doi:10.1016/j.cllc.2016.09.012 · Cited by 48
Self-citationAptamer-Mediated Nanotheranostics for Cancer Treatment: A Review
Ravichandran, G., & Rengan, A. K. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c01785 · Cited by 48
Eid, C., Palko, J. W., Katilius, E., & Santiago, J. G. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00886 · Cited by 47
Self-citationHigh-throughput, multiparameter analysis of single cells
Haselgrübler, T., Haider, M., Ji, B., Juhász, K., Sonnleitner, A., Balogi, Z., & Hesse, J. (2013) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-013-7485-x · Cited by 46
Plasma Proteomics of Renal Function: A Transethnic Meta-Analysis and Mendelian Randomization Study
Matías‐García, P. R., Wilson, R., Guo, Q., Zaghlool, S. B., Eales, J., Xu, X., Charchar, F. J., Dormer, J., Maalmi, H., Schlosser, P., et al. (2021) · Journal of the American Society of Nephrology · doi:10.1681/asn.2020071070 · Cited by 46
Erratum: Connecting genetic risk to disease end points through the human blood plasma proteome
Suhre, K., Arnold, M., Bhagwat, A. M., Cotton, R. J., Engelke, R., Raffler, J., Sarwath, H., Thareja, G., Wahl, A., DeLisle, R. K., et al. (2017) · Nature Communications · doi:10.1038/ncomms15345 · Cited by 45
Self-citationMasvekar, R., Wu, T., Kosa, P., Barbour, C., Fossati, V., & Bielekova, B. (2019) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2018.11.032 · Cited by 45
Saito, S., Hirose, K., Tsuchida, M., Wakui, K., Yoshimoto, K., Nishiyama, Y., & Shibukawa, M. (2015) · Chemical Communications · doi:10.1039/c5cc07268a · Cited by 45
Smith, E., Croca, S. C., Waddington, K. E., Sofat, R., GRIFFIN, M. B., Nicolaides, A. N., Isenberg, D. A., Pineda‐Torra, I., Rahman, A., & Jury, E. C. (2016) · Science Immunology · doi:10.1126/sciimmunol.aah4081 · Cited by 45
Wu, D., Katilius, E., Olivas, E., Milutinovic, M. D., & Walt, D. R. (2016) · Analytical Chemistry · doi:10.1021/acs.analchem.6b02451 · Cited by 45
Self-citationA Bottom-Up Approach for Developing Aptasensors for Abused Drugs: Biosensors in Forensics
Celikbas, E., Hanoglu, S. B., Evran, S., Coşkunol, H., & Tımur, S. (2019) · Biosensors · doi:10.3390/bios9040118 · Cited by 42
Pioglitazone regulates myelin phagocytosis and multiple sclerosis monocytes
Natrajan, M. S., Komori, M., Kosa, P., Johnson, K. R., Wu, T., Franklin, R. J. M., & Bielekova, B. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.260 · Cited by 40
Pass, H. I., Alimi, M., Carbone, M., Yang, H., & Goparaju, C. M. V. (2020) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-20-0083 · Cited by 39
Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology
Amero, P., Khatua, S., Rodriguez‐Aguayo, C., & Lopez‐Berestein, G. (2020) · Cancers · doi:10.3390/cancers12102889 · Cited by 39
SPARK-seq: A high-throughput platform for aptamer discovery and kinetic profiling
Luo, G., Song, J. T., Fu, Y., Jiang, Y., Gao, Y., Zhong, Z., Li, L., Wei, Y., Jia, H., Guo, L., et al. (2026) · Science · doi:10.1126/science.adv6127 · Cited by 37
Coyne, J., Davis, B., Kauffman, D., Zhao, N., & Wang, Y. (2017) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.7b00718 · Cited by 37
Duo, J., Chiriac, C., Huang, R. Y. ‐., Mehl, J. T., Chen, G., Tymiak, A. A., Sabbatini, P., Pillutla, R. C., & Zhang, Y. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.7b05277 · Cited by 37
Lopez-Silva, C., Surapaneni, A., Coresh, J., Reiser, J., Parikh, C. R., Obeid, W., Grams, M. E., & Chen, T. K. (2022) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.11700921 · Cited by 36
Rethinking nucleic acids from their origins to their applications
Benner, S. A. (2023) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2022.0027 · Cited by 36
Harnessing Nucleic Acids Nanotechnology for Bone/Cartilage Regeneration
Han, Y., Cao, L., Li, G., Zhou, F., Bai, L., & Su, J. (2023) · Small · doi:10.1002/smll.202301996 · Cited by 36
Alternative splicing in lung influences COVID-19 severity and respiratory diseases
Nakanishi, T., Willett, J., Farjoun, Y., Allen, R. J., Guillén‐Guío, B., Adra, D., Zhou, S., & Richards, J. B. (2023) · Nature Communications · doi:10.1038/s41467-023-41912-4 · Cited by 35
Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome
Moin, A. S. M., Sathyapalan, T., Diboun, I., Elrayess, M. A., Butler, A. E., & Atkin, S. L. (2021) · Scientific Reports · doi:10.1038/s41598-021-84586-y · Cited by 34
Cederberg, K. L. J., Hanif, U., Sempere, V. P., Hedou, J. J., Leary, E. B., Schneider, L. D., Lin, L., Zhang, J., Morse, A. M., Blackman, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147983 · Cited by 34
In vitro evolution of ribonucleases from expanded genetic alphabets
Jerome, C. A., Hoshika, S., Bradley, K. M., Benner, S. A., & Biondi, E. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2208261119 · Cited by 34
Metadata
- Authors
- Kraemer, S., Vaught, J. D., Bock, C., Gold, L., Katilius, E., Keeney, T. R., Kim, N., Saccomano, N. A., Wilcox, S. K., Zichi, D., & Sanders, G. M.
- Affiliations
- SomaLogic (United States) (US)
- University of Colorado Boulder (US)
- Corresponding author
- Saccomano, Nicholas A.
- Sanders, Glenn M.
- ORCID
- Wilcox, Sheri K.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-10-17
- Volume
- 6
- Issue
- 10
- Pages
- e26332
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3195687
- OpenAlex
- W1976531401
- Cited by
- 310
- References
- 11
- Citations by year
- 2026: 21 · 2025: 23 · 2024: 36 · 2023: 21 · 2022: 37 · 2021: 25 · 2020: 22 · 2019: 16 · 2018: 17 · 2017: 17 · 2016: 17 · 2015: 21 · 2014: 14 · 2013: 7 · 2012: 11
- FWCI
- 4.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced Biosensing Techniques and Applications
- Physical Sciences › Chemistry › Spectroscopy › Advanced Proteomics Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Advanced biosensing and bioanalysis techniques
- Keywords
- SOMAmer, biomarker discovery, plate-based assay, microarray hybridization, automated assay, diagnostic applications
- MeSH terms
- Automation, Biological Assay, Humans, Nucleic Acids, Oligonucleotides, Reproducibility of Results, Biomarkers, Case-Control Studies, Titrimetry, Diagnostic Techniques and Procedures, Proteomics, Limit of Detection
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.